{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:57:47Z","timestamp":1762505867011,"version":"3.41.2"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1097\/igc.0b013e31823c3219","type":"journal-article","created":{"date-parts":[[2012,1,7]],"date-time":"2012-01-07T07:43:25Z","timestamp":1325922205000},"page":"280-285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prognostic Impact of the History of Breast Cancer and of Hormone Therapy in Uterine Carcinosarcoma"],"prefix":"10.1016","volume":"22","author":[{"given":"Takashi","family":"Uehara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Onda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Togami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukuru","family":"Amano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiro","family":"Tanikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morio","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun-ichi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyasu","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Kasamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e31823c3219_bb0005","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0140-6736(94)92692-1","article-title":"Risk of endometrial cancer after tamoxifen treatment of breast cancer","volume":"343","author":"van Leeuwen","year":"1994","journal-title":"Lancet."},{"key":"10.1097\/IGC.0b013e31823c3219_bb0010","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1093\/jnci\/91.19.1654","article-title":"Tamoxifen therapy for breast cancer and endometrial cancer risk","volume":"91","author":"Bernstein","year":"1999","journal-title":"J Natl Cancer Inst."},{"key":"10.1097\/IGC.0b013e31823c3219_bb0015","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(00)02677-5","article-title":"Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres\u2019 ALERT Group. Assessment of liver and endometrial cancer risk following tamoxifen","volume":"356","author":"Bergman","year":"2000","journal-title":"Lancet."},{"key":"10.1097\/IGC.0b013e31823c3219_bb0020","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.breast.2005.09.007","article-title":"Toremifene: an evaluation of its safety profile","volume":"15","author":"Harvey","year":"2006","journal-title":"Breast (Edinburgh, Scotland)."},{"key":"10.1097\/IGC.0b013e31823c3219_bb0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.AOG.0000131620.67911.03","article-title":"Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?","volume":"104","author":"Slomovitz","year":"2004","journal-title":"Obstet Gynecol."},{"key":"10.1097\/IGC.0b013e31823c3219_bb0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/cncr.22734","article-title":"Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer: comparison of cohorts treated with and without tamoxifen","volume":"110","author":"Saadat","year":"2007","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e31823c3219_bb0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/gyno.1993.1118","article-title":"Role of prolonged stimulation of tamoxifen therapy in the etiology of endometrial sarcomas","volume":"49","author":"Altaras","year":"1993","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31823c3219_bb0040","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1525-1438.1995.05040310.x","article-title":"Is there an association between long-term tamoxifen treatment and the development of carcinosarcoma (malignant mixed Mullerian tumor) of the uterus?","volume":"5","author":"Evans","year":"1995","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e31823c3219_bb0045","first-page":"2015","article-title":"Long-term tamoxifen treatment: a possible aetiological factor in the development of uterine carcinosarcoma: two case-reports and review of the literature","volume":"20","author":"Fotiou","year":"2000","journal-title":"Anticancer Res."},{"key":"10.1097\/IGC.0b013e31823c3219_bb0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1006\/gyno.2000.5859","article-title":"Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer","volume":"78","author":"Deligdisch","year":"2000","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31823c3219_bb0055","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1525-1438.2000.010004280.x","article-title":"Uterine carcinosarcomas in patients receiving tamoxifen. A report of 19 cases","volume":"10","author":"McCluggage","year":"2000","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e31823c3219_bb0060","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/ijgc-00009577-200209000-00015","article-title":"Tamoxifen-related uterine carcinosarcomas occur under\/after prolonged treatment: report of five cases and review of the literature","volume":"12","author":"Kloos","year":"2002","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e31823c3219_bb0065","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/ijgc-00009577-200603000-00063","article-title":"Uterine sarcomas in breast cancer patients treated with tamoxifen","volume":"16","author":"Arenas","year":"2006","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e31823c3219_bb0070","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/jnci\/djh007","article-title":"Risk of malignant mixed Mullerian tumors after tamoxifen therapy for breast cancer","volume":"96","author":"Curtis","year":"2004","journal-title":"J Natl Cancer Inst."},{"key":"10.1097\/IGC.0b013e31823c3219_bb0075","unstructured":"National Cancer Center, The Center for Cancer Control and Information Services. Cumulative cancer incidence\/mortality risk. Cancer statistics in Japan 2008. Available at: http:\/\/www. ganjoho.jp\/public\/statistics\/backnumber\/odjrh3000000vdf1-att\/ fig 09.pdf 2008. Accessed January 8, 2009."},{"key":"10.1097\/IGC.0b013e31823c3219_bb0080","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/gyno.1997.4827","article-title":"Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study","volume":"67","author":"Sartori","year":"1997","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31823c3219_bb0085","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<512::AID-CNCR13>3.0.CO;2-4","article-title":"Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients","volume":"82","author":"Iwasa","year":"1998","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e31823c3219_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004347-199001000-00001","article-title":"Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases","volume":"9","author":"Silverberg","year":"1990","journal-title":"Int J Gynecol Pathol."},{"key":"10.1097\/IGC.0b013e31823c3219_bb0095","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000183250","article-title":"Serum and tissue LDH levels in patients with breast\/gynaecological cancer and benign diseases","volume":"67","author":"Koukourakis","year":"2009","journal-title":"Gynecol Obstet Invest."},{"key":"10.1097\/IGC.0b013e31823c3219_bb0100","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1525-1438.2007.01025.x","article-title":"The risk of developing uterine sarcoma after tamoxifen use","volume":"18","author":"Lavie","year":"2008","journal-title":"Int J Gynecol Cancer."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24058390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24058390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T16:44:12Z","timestamp":1753202652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24058390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1048891X24058390"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e31823c3219","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Impact of the History of Breast Cancer and of Hormone Therapy in Uterine Carcinosarcoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e31823c3219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}